EHAVE, Inc. (EHVVF)
| Market Cap | 431.49K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -2.01M |
| Shares Out | 359.57M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 75,000 |
| Average Volume | 295,766 |
| Open | 0.0012 |
| Previous Close | 0.0015 |
| Day's Range | 0.0010 - 0.0015 |
| 52-Week Range | 0.0001 - 0.0095 |
| Beta | 618.86 |
| RSI | 41.83 |
| Earnings Date | May 16, 2025 |
About EHAVE
EHAVE, Inc., a healthcare company, develops medical psychedelics and mental health data platform that integrates with its proprietary and third-party assessment and therapeutic digital applications in Canada. The company offers MegaTeam and Ninja Reflex, a clinically validated digital assessment and rehabilitation software for the patient; and adapts custom and third-party clinically validated digital assessment and rehabilitation software for patient engagement and data modeling. It also offers Ehave Dashboard, a mental health informatics plat... [Read more]
Financial Performance
Financial StatementsNews
Mycotopia Therapies Inc. Announces Name Change to AIBiotics, Inc. and Symbol Change to AIBT
MIAMI, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. dba AIBotics (“AIBotics” or the “Company”) (OTC: TPIA) and a wholly owned subsidiary of Ehave (OTC: EHVVF), a developer and manager of...
Making Ehave Great Again
Ehave, Inc. Announces Return to Current SEC Filing Status and OTC Pink Market Trading Ehave, Inc. Announces Return to Current SEC Filing Status and OTC Pink Market Trading
Rushnet, Inc Announces Agreement with Ehave for Mental Health Lab Testing
ALPHARETTA, GA / ACCESSWIRE / May 9, 2023 / RushNet, Inc (OTC PINK:RSHN), (the "Company") announces agreement with Ehave, Inc. (OTC Pink: EHVVF), announces agreement with Ehave, Inc. (OTC Pink: EHVVF)...
Ehave Provides Progress Update on its HPPD Study with University of Melbourne
Potential of monetizing HPPD research by identifying biomarkers to identify individuals who have a higher risk of developing HPPD if they take psychedelics Potential of monetizing HPPD research by ide...
Ehave, Inc. Announces its KetaDASH Mobile Unit will be Delivered to Miami Beach on June 10, 2022
MIAMI, June 03, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its KetaDASH subsidiary will accept delive...
Ehave, Inc. Announces Psychedelics Precision Medicine Platform For Clinical Research
MIAMI, June 01, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its KetaDASH subsidiary will begin using p...
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ
Ehave owns approximately 9,793,754 shares of Mycotopia Therapies valued at more than $24 million, as of Friday's closing price; Plans partial distribution to shareholders Ehave owns approximately 9,79...
Ehave Announces MetaHealthU Will Enter The Market With A Focus On HPPD
MIAMI, April 19, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its MetaHealthU mobile application platfo...
Ehave Continues Expansion Of KetaDASH Mobile Psychedelic Service By Providing Licensed Psychotherapists And Registered Nurses
MIAMI, March 03, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today it will partner with Heally, the all-in-o...
Ehave, Inc. Licensing Partner Vastmindz Seen By Millions Of Viewers On Unicorn Hunter
MIAMI, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today that its AI technology licensing partner, ...
Ehave, Inc. Launches KetaDASH, Its In-Home Ketamine Therapy In The San Francisco And Sacramento Market
MIAMI, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today that its wholly-owned subsidiary, KetaDASH...
Ehave, Inc. Expands Its KetaDASH Brand And Begins Producing Revenue With The Purchase Of California Based Rejuv IV
MIAMI, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, reaffirms its commitment to shareholders to launch its Ket...
Ehave Issues Shareholder Letter and Provides Corporate Update
MIAMI, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, today issued a letter to shar...
Ehave Plans Stock Distribution; Mycotopia Therapies Plans To Merge With Ei. Ventures
Mycotopia and Ei.Ventures announced the signing of an LOI to explore a merger and the formation of PSLY.COM, a $360 Million transaction, and will apply to list shares on NASDAQ; Ehave plans to spin ou...
Ehave, Inc. To Sponsor Major Psychedelics Conference, Wonderland: Miami
Wonderland: Miami is hosted by Microdose and engages some of the greatest minds in the Psychedelic Sector, by fostering creative and professional growthMiami, Florida--(Newsfile Corp. - November 5, 20...
2021 Psychedelic Investor Guide Released
MIAMI, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today its wholly ow...
Ehave Hires Contract Research Organization To Conduct Ketamine Clinical Trial In Miami, Florida
Ehave one of the first companies to pioneer the collection of certain data points, as well as to seek to understand how ketamine can potentially resolve issues in the brain through a process called ne...
Psychedelic Stock Review Initiates Coverage on Ehave Inc.
MIAMI, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced t...
Ehave Announces Inclusion in the 2021 Psychedelic Investor Guide
MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today that it has ...
Ehave Appoints Board-Certified Gastroenterologist And Licensed Physician Dr. Rahul Dixit To Its Medical Advisory Board
MIAMI, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today Dr. Rahul Di...
Ehave Announces Update On Ehave Medical App With The Launch Of Covid Vaccine Passport Going Live Shortly
Ehave's Covid Passport provides small businesses a tool to verify Covid-19 vaccination, and a suite of products to improve both the mental and overall health of individuals. Ehave's Covid Passport pro...
Ehave Files 6-K Disclosing LOI Details For The Acquisition Of Moksha Digital Software
MIAMI, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced t...
Ehave Accelerates Growth With LOI To Acquire India Based Moksha Digital, A Medical Imaging Software Provider
MIAMI and BANGALORE, India, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to...
Ehave Files 6-K Disclosing Research Project Agreement
MIAMI, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced t...
Ehave Releases Additional Information On Partnership With Cutting Edge Data Provider As It Expands Capabilities
Ehave to provide data integrity and patient privacy while allowing patients to share their medical data with medical providers and research organizations Ehave to provide data integrity and patient pr...